Data on Down’s Syndrome test “mishandled”
Sequenom’s shares plunge
A San Diego company which had been developing a non-invasive test for Down’s
Syndrome is in hot water after admitting that some of its data was "mishandled"
by employees. Sequenom’s shares plunged 75% when investors learned that there
were "significant concerns". Officials have declined to say whether fraud was
involved. Four people in R&D have been suspended and an independent
investigation has been launched. Several class-actions suits have been filed
against the company.
Sequenom’s test works by examining minute amounts of fetal DNA or RNA in the
mother’s blood. It would provide an alternative to more invasive methods such as
amniocentesis, which carry a small risk of miscarriage. In most cases the child
would be aborted if the test were reliably positive. ~ Nature, May
6; Wall
Street Journal, Apr 30
- Queensland legalises ‘assisted dying’ - September 19, 2021
- Is abortion a global public health emergency? - April 11, 2021
- Dutch doctors cleared to euthanise dementia patients who have advance directives - November 22, 2020
More Stories
A first in France: a trans mum and a trans dad
Trigger warning: if you are easily confused by gender pronouns, this story from France may cause heart palpitations. February 19...
Nigerian power couple convicted in London over organ trafficking plot
In May last year, a young Nigerian man stumbled into a police station into the English town of Staines, in...
Cease and desist: Dutch sperm donor who has fathered 550 children is being sued
A Dutch woman and a foundation for children of sperm donors are suing a Dutch man for fathering too many...
Should intractable mental illness make you eligible for euthanasia?
Canada is in the middle of a vigorous debate about whether incurable mental illness is grounds for Medical Assistance in...
Belgium to permit multiple gender ID changes
Belgium will permit people to change their gender identity as often as they want. The Minister of Justice, Vincent Van...
Nature’s foray into politics may have backfired
In the 2020 election, a swag of high-profile science journals, including Nature, Science, The Lancet, and the New England Journal...